NASDAQ: SRTA
Strata Critical Medical, Inc.
$5.33
▼ -0.05 (-1.02%)as of 2026-09-03
1-year price · 252 sessions
Key stats
52-week range$5.33
$3.99$6.47
Today
- Open
- 5.44
- Day high
- 5.46
- Day low
- 5.30
- Prev close
- 5.39
- Volume
- 96K
Valuation
- Mkt cap
- $475M
- P/E (TTM)
- 10.8
- EPS (TTM)
- $0.50
- P/B
- 1.7
- P/S
- 1.9
Dividend
- Yield
- —
- Per share
- —
Insider & institutional activity · SEC Form 4 / 13F
- ▼Insiders net selling -$450K over the last 3 months (0 open-market buys, 5 sales)
Strata Critical Medical, Inc. (SRTA) is a Industrials company listed on NASDAQ. The stock is up 31% over the past year. Over the trailing 3 months, insiders filed 0 open-market buys and 5 sales (SEC Form 4).
Strata Critical Medical, Inc. (SRTA) financials & analyst ratings
Fundamentals (TTM)
Margins
Gross margin20.6%
Operating margin-8.0%
Net margin15.7%
FCF margin-17.1%
Growth & returns
Revenue growth+0.6%
Revenue growth (fwd)+22.6%
EPS growth+316.1%
Return on equity14.4%
Return on assets12.1%
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
SRTA earnings date, history & EPS estimates
Next earnings
Nov 9, 2026in NaN days
EPS est $0.01 · Revenue est $73M
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -281.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 4, 2026 | $-0.02 | $-0.12 | -500.0% | $73M | +7.2% |
| May 6, 2026 | $-0.04 | $0.03 | +175.0% | $67M | +5.8% |
| Mar 3, 2026 | $0.01 | $-0.07 | -800.0% | $23M | -63.7% |
| Mar 13, 2025 | $-0.12 | $-0.12 | +0.0% | $54M | +6.7% |
| Mar 12, 2024 | $-0.13 | $-0.23 | -76.9% | $47M | -1.9% |
| May 11, 2023 | $-0.21 | $-0.14 | +33.3% | $45M | +11.8% |
| Mar 15, 2023 | $-0.19 | $-0.23 | -21.1% | $38M | +6.0% |
| Nov 10, 2022 | $-0.14 | $-0.13 | +7.1% | $46M | +18.2% |
| Aug 9, 2022 | $-0.13 | $-0.09 | +30.8% | $36M | +31.0% |
| Feb 10, 2022 | $-0.21 | $-0.13 | +38.1% | $25M | +51.2% |
| Dec 20, 2021 | $-0.14 | $-0.13 | +7.1% | $20M | +47.7% |
| Aug 16, 2021 | $-0.01 | $-0.15 | -2622.3% | $13M | -5.1% |
SRTA insider trading activity (SEC Form 4)
Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$449.6K
Insider trades by month Buys Sells
Aug
Nov
Dec
May
Jun
Aug
Context3-month price -12.7%
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | Love Reginalddirector | Sell | 5,091 | $5.75 |
| Aug 3, 2026 | Cohen Amirofficer: Chief Accounting Officer | Grant | 27,420 | — |
| Aug 3, 2026 | Cohen Amirofficer: Chief Accounting Officer | Tax | 34,015 | $5.09 |
| Aug 3, 2026 | PHILIP EDWARD Mdirector | Grant | 30,913 | — |
| Aug 3, 2026 | Love Reginalddirector | Grant | 37,675 | — |
| Aug 3, 2026 | Cook William L. IIIdirector | Grant | 44,438 | — |
| Aug 3, 2026 | WIESENTHAL ROBERT Sdirector | Grant | 50,234 | — |
| Aug 3, 2026 | LAUCK ANDREWdirector | Grant | 35,260 | — |
| Aug 3, 2026 | Wunsch Scott Mofficer: CEO, Logistics | Grant | 57,172 | — |
| Aug 3, 2026 | Wunsch Scott Mofficer: CEO, Logistics | Tax | 13,992 | $5.09 |
| Aug 3, 2026 | Heyburn William A.director, officer: Co-CEO and CFO | Grant | 181,071 | — |
| Aug 3, 2026 | Heyburn William A.director, officer: Co-CEO and CFO | Grant | 179,160 | — |
| Aug 3, 2026 | Heyburn William A.director, officer: Co-CEO and CFO | Tax | 199,209 | $5.09 |
| Aug 3, 2026 | Tomkiel Melissa M.director, officer: Co-CEO and General Counsel | Grant | 208,929 | — |
| Aug 3, 2026 | Tomkiel Melissa M.director, officer: Co-CEO and General Counsel | Grant | 206,953 | — |
Source: SRTA SEC Form 4 filings, latest Aug 13, 2026. For informational purposes only — not investment advice.
See the full SRTA insider & 13F page →Track SRTA with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free